China drug licensing deals surge nearly 10-fold in value since 2021
Source: SeekingAlpha
2026-02-19 13:31:04 ET
More on AbbVie, AstraZeneca PLC, etc.
- Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game
- Pfizer: The Rebound Looks Unsustainable
- AbbVie: Dominating Immunology While Building Oncology Upside
- Merck posts new Enflonsia RSV data in infants
- Merck reports positive phase 3 second-season RSV data for ENFLONSIA
Read the full article on Seeking Alpha
For further details see:
China drug licensing deals surge nearly 10-fold in value since 2021
Moderna Inc.
NASDAQ: MRNA
MRNA Trading
-3.49% G/L:
$52.3088 Last:
3,446,368 Volume:
$54.31 Open:
MRNA Latest News
MRNA Stock Data
$16,877,354,918
348,095,445
0.39%
298
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
